RETATRUTIDE 50MG - User Manual & Research Protocol Guide

 Product Information

• Compound: Retatrutide
• Strength: 50 mg per vial
• Form: Lyophilized powder
• Category: GLP-1 / GIP / Glucagon Receptor Agonist (Research)
• Intended Use: Laboratory research only
• Storage (Unmixed): 2–8°C (Refrigerated)
• Storage (After Reconstitution): Refrigerate and use within 30 days

Retatrutide is being studied as a triple receptor agonist, targeting:

• GLP-1 receptor – Appetite & glucose regulation
• GIP receptor – Metabolic modulation
• Glucagon receptor – Energy expenditure research

This multi-receptor activity is currently under investigation for metabolic and body composition research models.

Supplies Needed

• Bacteriostatic Water
• U-100 Insulin Syringe
• Alcohol swabs

Step-by-Step Instructions

1. Clean vial tops with alcohol.
2. Draw bacteriostatic water into the syringe.
3. Slowly inject water along the inside wall of the vial.
4. Gently swirl until fully dissolved.
   ❗ Do NOT shake.
5. Store refrigerated after mixing.

(Research Reference Structure Only – Not Medical Advice)

Option 1: Add 10 mL Bacteriostatic Water

Total Peptide: 50 mg

Final Concentration: 5 mg per mL

U-100 Syringe Conversion (approximate):

• 10 units (0.1 mL) = 0.5 mg
• 20 units (0.2 mL) = 1 mg
• 30 units (0.3 mL) = 1.5 mg
• 40 units (0.4 mL) = 2 mg
• 50 units (0.5 mL) = 2.5 mg
  

Option 2: Add 5 mL Bacteriostatic Water

Final Concentration: 10 mg per mL

U-100 Syringe Conversion (approximate):

• 5 units (0.05 mL) = 0.5 mg
• 10 units (0.1 mL) = 1 mg
• 20 units (0.2 mL) = 2 mg
• 30 units (0.3 mL) = 3 mg
• 40 units (0.4 mL) = 4 mg
• 50 units (0.5 mL) = 5 mg

• Frequently studied as once-weekly subcutaneous administration
• Gradual titration protocols evaluated in controlled research
• Typical research duration: 8–24 weeks

• For laboratory research use only
• Not for human consumption
• Not FDA approved
• Maintain sterile technique
• Keep refrigerated
• Keep out of reach of children